16 reports

  • MARKET SHARE ANALYSIS 2014
  • Scope of the report

The sexually transmitted infectious diseases burden is increasing worldwide, and it is one of the major health challenges.

  • Infectious Disease
  • Point Of Care Testing
  • Alere Inc.
  • DiaSorin S.p.A.
  • Roche Group
  • INFECTIOUS DISEASE TEST MARKET
  • The Infectious Disease Blood Screening Market

However, no one technology can satisfy clinical demand for infectious disease diagnostics.

  • Diagnostics
  • Immunodiagnostics
  • Infectious Disease
  • Molecular Diagnostics
  • DiaSorin S.p.A.
  • INFECTIOUS DISEASE TESTING
  • MARKET SIZE AND FORECAST

It includes immunoproteins for the detection of various diseases such as infectious diseases, oncology, and autoimmune diseases.

  • Biotech Diagnostics
  • Infectious Disease
  • World
  • Beckman Coulter, Inc.
  • DiaSorin S.p.A.

REAGENTS AND KITS USED IN THE DIAGNOSIS OF INFECTIOUS DISEASES ARE NOT INCLUDED IN THIS CATEGORY.

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Infectious Disease
  • DiaSorin S.p.A.
  • MICROBIOLOGY

Immunoassays for Infectious Diseases ##.

  • In Vitro Diagnostics
  • Infectious Disease
  • Point Of Care Testing
  • Beckman Coulter, Inc.
  • DiaSorin S.p.A.
  • DIASORIN S.P.A. SUMMARY

More than $## million in IVD sales in Mexico are attributed to infectious disease testing.

  • In Vitro Diagnostics
  • Infectious Disease
  • Becton Property Group
  • DiaSorin S.p.A.
  • Roche Group

BIOMERIEUX PRODUCTS ARE USED DIAGNOSING AND MANAGING INFECTIOUS DISEASES, CARDIOVASCULAR DISEASES AND TARGETED CANCERS.

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Molecular Diagnostics
  • DiaSorin S.p.A.
  • 4.9 ALERE INC

IT OFFERS TESTING AND MONITORING PRODUCTS INCLUDING POINT-OF-CARE AND LABORATORY TESTS WITHIN THE INFECTIOUS DISEASE, CARDIOMETABOLIC DISEASE, TOXICOLOGY AND PATIENT SELF-TESTING DOMAINS.

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Molecular Diagnostics
  • DiaSorin S.p.A.

ALERE INC (ALERE) IS ONE OF THE LEADING PROVIDERS OF POINT-OF-CARE DIAGNOSTICS SOLUTIONS AND SERVICES WITH FOCUS ON CARDIOLOGY, WOMEN' S HEALTH, INFECTIOUS DISEASES, DIABETES, ONCOLOGY, AND TOXICOLOGY.

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Molecular Diagnostics
  • DiaSorin S.p.A.
  • MARKET SHARE ANALYSIS 2014
  • Market trends

The company offers rapid POC diagnostic tests that detect infectious diseases.

  • Hepatitis
  • HIV AIDS
  • Infectious Disease
  • Alere Inc.
  • DiaSorin S.p.A.
  • Vendor landscape

It is one of the prominent vendors in the market and offers high-performance healthcare solutions through rapid diagnostic tests for infectious diseases, toxicology, and cardiometabolic diseases.

  • Infectious Disease
  • Alere Inc.
  • bioMerieux S.A.
  • Cepheid
  • DiaSorin S.p.A.
  • DIASORIN S.P.A

This has resulted in lower rates of infectious disease transmission.

  • Biotech Diagnostics
  • Blood Supply
  • Infectious Disease
  • Molecular Diagnostics
  • DiaSorin S.p.A.

One: Executive Summary ## diabetes, infectious diseases.

  • In Vitro Diagnostics
  • Infectious Disease
  • Point Of Care Testing
  • Alere Inc.
  • DiaSorin S.p.A.
  • Vendor landscape

Point-of-care diagnostic tests for infectious diseases and cancer can be performed at or near the site of patient care.

  • Infectious Disease
  • World
  • Forecast
  • Market Size
  • DiaSorin S.p.A.
  • Deal Sub Type
  • Deal Type Deal in Brief

This is DiaSorin' s first fungal infectious disease target.

  • Infectious Disease
  • United States
  • Company
  • Demand
  • DiaSorin S.p.A.
  • DIASORIN S.P.A, MAJOR PRODUCTS AND SERVICES
  • DIASORIN S.P.A - KEY FACTS

As of June, 2018 REAGENT ASRS - INFECTIOUS DISEASE REAGENT ASRS - INFECTIOUS DISEASE PRODUCT OVERVIEW REAGENT ASRS - INFECTIOUS DISEASE - PRODUCT STATUS MARKET CATEGORY DEVELOPED BY PIPELINE TERRITORY HIGHEST STAGE OF DEVELOPMENT DEVICE CLASS REG

  • Diagnostics
  • In Vitro Diagnostics
  • Infectious Disease
  • Pathology
  • DiaSorin S.p.A.